Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115055) titled 'Research on ILD-LC Risk Assessment Model Integrating Radiomics and Clinical Data' on Dec. 22, 2025.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: Huzhou Center Hospital
Condition:
Interstitial lung disease combined with lung cancer
Intervention:
Interstitial group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-12-26
Target Sample Size: Interstitial group:220;Interstitial lung cancer group:110;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=301712
Published by HT Digital Conten...